India and the US Thursday signed an agreement to develop low-cost medical technologies and share expertise on biomedical research.
The agreement was signed here between the National Institute of Biomedical Imaging and Bioengineering, a body of the National Institute of Health (NIH), the US, and the Department of Biotechnology under India's ministry of science and technology.
Global Drive to Improve Maternal and Child Health Launched in the U.S.
A global coalition of governments and organizations will launch a major advocacy drive today entitled Deliver Now for Women and Children.
Advertisement
According to the ministry, the objective of the collaboration is "development of low-cost diagnostics and therapeutic medical technologies".
Speaking on the occasion, Minister for Science and Technology Kapil Sibal underlined the need of funds to pursue research and innovation in the public health sector.
NIH director Elias A. Zerhouni was also present when the pact was signed.
The major focus of the agreement will be on infectious diseases, trauma, maternal and child health and chronic diseases like diabetes, hypertension and cardiovascular diseases, the ministry said.
The collaboration will include organization of workshops and meetings to share experiences and scientific information.
It will facilitate direct links among centres of excellence and institutions in both countries. The agreement is expected to enable collaboration among scientists and engineers in centres of excellence in both countries to conduct research, research training and technology development.
Source: ANI
VEN/C
Advertisement
NIH director Elias A. Zerhouni was also present when the pact was signed.
The major focus of the agreement will be on infectious diseases, trauma, maternal and child health and chronic diseases like diabetes, hypertension and cardiovascular diseases, the ministry said.
The collaboration will include organization of workshops and meetings to share experiences and scientific information.
It will facilitate direct links among centres of excellence and institutions in both countries. The agreement is expected to enable collaboration among scientists and engineers in centres of excellence in both countries to conduct research, research training and technology development.
Source: ANI
VEN/C
Advertisement
Advertisement
|
Advertisement
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.